Cargando…
Unearthing EGFR Mutations and the Rewards of Persistence in Precision Oncology: Breaching the 10-Year Survival Barrier in Metastatic NSCLC With Active Disease
Autores principales: | Singh, Pawan Kumar, Kumar, Rajender, Bal, Amanjit, Gupta, Nalini, Kapoor, Rakesh, Prasad, Kuruswamy Thurai, Singh, Navneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998025/ https://www.ncbi.nlm.nih.gov/pubmed/32031456 http://dx.doi.org/10.1200/JGO.19.00357 |
Ejemplares similares
-
Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
por: Garg, Gaurav, et al.
Publicado: (2021) -
A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
por: Roy, Mohana, et al.
Publicado: (2022) -
Endoscopic ultrasound (with an echobronchoscope)-guided fine-needle aspiration for diagnosis of a mediastinal lesion in a mechanically ventilated patient: A case report and systematic review of the literature
por: Prasad, Kuruswamy Thurai, et al.
Publicado: (2016) -
Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects
por: Dhooria, Sahajal, et al.
Publicado: (2018) -
A real-world study of the dosing and tolerability of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis
por: Dhooria, Sahajal, et al.
Publicado: (2020)